A purpose-led portfolio of companies, working to unify all aspects of the alternative and emerging therapeutics industry and bridge the gap between doctors, suppliers, pharmacists and patients.

Vitura Health Limited is one of Australia’s leading emerging therapeutics groups, delivering a truly national distribution capability and the ability to service patients coast to coast across our vast country. Comprising of a number of aligned subsidiaries – Doctors on Demand, Canview, CDA Clinics, Cortexa, Cannadoc, BHC and Adaya – each brand is actively engaged in the evolution of the alternative medical sector for the better.

We’re committed to providing a seamless approach to patient treatment pathways, streamlined pharmacist access to legal medications and unparalleled prescriber education, developing industry-informed clinicians.

Underpinned by an innovative business model and a continuous improvement approach, Vitura Health leverages its downstream, asset-light strategy to focus on meeting the demands of this complex and growing industry.

At Vitura Health, we’re focused on changing medicine and transforming lives, while continuing to generate value for our shareholders, suppliers, partners, employees and medical communities.

Vitura Health Limited is listed on the ASX, under the code VIT.

Cannabis

Therapeutics

Health Care

Biotechnology

Vitura Health (ASX:VIT)

Geoff Cockerill

Erin Leckie

Robert Iervasi

Deanna Johns

Ryan Tattle

Tom Howitt

Vitura Health (ASX:VIT)

Org chart

Teams

Similar companies